Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1961 1
1962 2
1964 1
1965 3
1966 6
1967 13
1968 13
1969 16
1970 23
1971 17
1972 18
1973 16
1974 10
1975 14
1976 8
1977 3
1978 4
1979 8
1980 3
1981 6
1982 4
1983 8
1984 3
1985 4
1986 5
1987 4
1988 3
1989 2
1990 6
1991 1
1992 1
1993 6
1994 4
1995 8
1996 40
1997 46
1998 52
1999 70
2000 41
2001 63
2002 76
2003 84
2004 64
2005 88
2006 85
2007 80
2008 73
2009 80
2010 84
2011 77
2012 68
2013 59
2014 82
2015 62
2016 48
2017 52
2018 53
2019 51
2020 63
2021 66
2022 74
2023 59
2024 48

Search Results

1,913 results

Results by year

Filters applied: . Clear all
Page 1
Neuropharmacology of N,N-dimethyltryptamine.
Carbonaro TM, Gatch MB. Carbonaro TM, et al. Brain Res Bull. 2016 Sep;126(Pt 1):74-88. doi: 10.1016/j.brainresbull.2016.04.016. Epub 2016 Apr 25. Brain Res Bull. 2016. PMID: 27126737 Free PMC article. Review.
Psychedelics.
Nichols DE. Nichols DE. Pharmacol Rev. 2016 Apr;68(2):264-355. doi: 10.1124/pr.115.011478. Pharmacol Rev. 2016. PMID: 26841800 Free PMC article. Review.
Neurotoxicity of MDMA: Main effects and mechanisms.
Costa G, Gołembiowska K. Costa G, et al. Exp Neurol. 2022 Jan;347:113894. doi: 10.1016/j.expneurol.2021.113894. Epub 2021 Oct 13. Exp Neurol. 2022. PMID: 34655576 Review.
Adverse Effects After Ayahuasca Administration in the Clinical Setting.
Rocha JM, Rossi GN, Osório FL, Hallak JEC, Dos Santos RG. Rocha JM, et al. J Clin Psychopharmacol. 2022 May-Jun 01;42(3):321-324. doi: 10.1097/JCP.0000000000001536. Epub 2022 Mar 14. J Clin Psychopharmacol. 2022. PMID: 35289542 No abstract available.
Psychedelics and Psychedelic-Assisted Psychotherapy.
Reiff CM, Richman EE, Nemeroff CB, Carpenter LL, Widge AS, Rodriguez CI, Kalin NH, McDonald WM; the Work Group on Biomarkers and Novel Treatments, a Division of the American Psychiatric Association Council of Research. Reiff CM, et al. Am J Psychiatry. 2020 May 1;177(5):391-410. doi: 10.1176/appi.ajp.2019.19010035. Epub 2020 Feb 26. Am J Psychiatry. 2020. PMID: 32098487 Review.
Reviewing the Potential of Psychedelics for the Treatment of PTSD.
Krediet E, Bostoen T, Breeksema J, van Schagen A, Passie T, Vermetten E. Krediet E, et al. Int J Neuropsychopharmacol. 2020 Jun 24;23(6):385-400. doi: 10.1093/ijnp/pyaa018. Int J Neuropsychopharmacol. 2020. PMID: 32170326 Free PMC article. Review.
Use of Psychedelics for Pain: A Scoping Review.
Goel A, Rai Y, Sivadas S, Diep C, Clarke H, Shanthanna H, Ladha KS. Goel A, et al. Anesthesiology. 2023 Oct 1;139(4):523-536. doi: 10.1097/ALN.0000000000004673. Anesthesiology. 2023. PMID: 37698433 Free article. Review.
Medical Uses and Adverse Effects of Psilocybin.
Ghaznavi S, Bernardez LM, Stern TA. Ghaznavi S, et al. Prim Care Companion CNS Disord. 2024 May 28;26(3):23f03652. doi: 10.4088/PCC.23f03652. Prim Care Companion CNS Disord. 2024. PMID: 38815272 Free article.
1,913 results